TrialActa orthopaedica2021

Pexidartinib improves physical functioning and stiffness in patients with tenosynovial giant cell tumor: results from the ENLIVEN randomized clinical trial.

Michiel Van De Sande et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.